Prehypertension was defined as systolic blood pressure of 120 to 139 mm Hg and/or diastolic blood pressure of 80 to 89 mm Hg whereas hypertension was defined as systolic blood pressure of ≥140 mmHg and/or diastolic blood pressure of ≥90 mmHg (4) . Both prehypertension and hypertension were considered elevated blood pressure. The predictors of elevated blood pressure ) were determined using logistic regression; age, sex and covariates with P≤0.10 in the univariate analysis were included in the multivariable models.
The background characteristics of 273 patients followed-up have been reported (3) . Briefly, the mean age was 41.5 (9.8) years and 178 (65.2%) were females; 11 (4%) were current smokers, 31 (11.4%) were current alcohol drinkers, 12 (4.2%) were either overweight or obese, and 77 (28.2%) had received TB treatment since NUSTART enrolment 2-3 years previously. Five (1.8 %) had hypertension and 51 (18.7%) had either prehypertension or hypertensionwhich is elevated blood pressure in excess of 120/80mmHg. In multivariable logistic regression, age (OR 1.05 (1.0, 1.1) increased the risk of elevated blood pressure, but receiving TB treatment reduced the risk (OR: 0.25 (0.1, 0.7) of elevated blood pressure (Table 1) . Other covariates were not significant predictors.
In this analysis, we report a very high prevalence of elevated blood pressure. Although the prevalence of frank hypertension was low, the high prevalence of prehypertension (about 16.9%) is of concern, since similar to hypertension, prehypertension is associated with an increased risk of cardiovascular disease among the general population(5) and possibly among HIV-infected patients.
The lack of association with traditional modifiable risk factors for non-communicable diseases suggests that non-traditional risk factors, in addition to age, may be major contributors to the evolution of elevated blood pressure in this population. Although not receiving TB treatment could be one of those determinants, the mechanism underlying this association is difficult to explain. We suggest two possible explanations. First, those not on TB treatment could have latent or undiagnosed subclinical TB which could have compromised the integrity of blood vessels due cell-mediated immune response and chronic inflammation (6) . The damaged vessels would probably increase their risk of elevated blood pressure. The existence of widespread latent or subclinical TB in the NUSTART population is likely, based on our previous observation that TB treatment was associated with decreased mortality in these patients (2) . Second, mortality in this cohort, during NUSTART trial and 2-3 years follow-up, was high (approximately 40%; unpublished data). Given the many competing factors leading to death in this initially seriously ill population, it is possible that the association between being on TB treatment at the start of ART and elevated blood pressure after 2-3 years on ART is spurious.
Further research is needed to investigate TB and other potential determinants of elevated blood pressure to help control this condition among patients starting ART when malnourished.
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